Abbott kept the long term cash cow portions of the business...
Nutritional products such as Similac & Ensure & animal health care products & a human pharma portfolio with too many offerings for me to mention here.
Minimally invasive coronary devices help physicians open coronary blockages to restore blood flow & similar treatments for blocked blood vessels in peripheral areas outside the heart. Products for peripheral artery disease address blockages in the abdomen and legs. Carotid artery stenting products help treat stroke-causing blockages in the neck. A pioneer in closure technologies, Abbott offers both suture-based and clip-based closure products for securing the vascular access site after coronary and peripheral catheterizations.
Diagnostic portfolio of immunoassay, hematology & molecular products:
1. Immunodiagnostic instruments and tests that detect disease and other medical conditions, including cancer, cardiovascular disease, infectious disease, thyroid disease, drug abuse, fertility and pregnancy.
2. Hematology analyzers to provide fast, accurate results for identification and monitoring infection, leukemia, chemotherapy and a variety of anemic conditions.
3. Molecular diagnostics to help detect genetic disorders, guide the treatment of breast and lung cancers, monitor people with HIV and even identify the best potential donors for bone marrow transplants.
Vision care products:
1. Refractive eye surgery (LASIK)
2. Monofocal and multifocal intraocular lenses (IOL) which are implanted into the eye during cataract surgery to help improve sight.
3. Corneal contact lens cleaning solutions (Blink RevitaLens Ocutec)
Diabetic blood glucose monitoring products.
I got all this off their website.
Also read ABBV form 10 on Edgar & personally I think Abbott is the plum!
I agree with your hold sentiment.
They're trading a bit too high on the forward P/E when compared to other pharma/device equities.
I still like their biz & I'd be looking to pick up a little ABT below $25.
Samsung is making huge strides towards dominating the mobile arena but they don't have Apple's ecosphere (iTunes...) Samsung does however have a strong presence in the home with television & kitchen appliances which presents them with the opportunity to develop connectivity in an area which I believe Apple should pursue aggressively (in fact Apple is selling Nest smart thermostats in the Apple store which indicates they are aware of the importance of networking with home appliances.)
Instead of all the brouhaha about increased dividends (Einhorn is a punk) I'd like to see them buy LG ($13.6B market cap) (as an aside LG makes glass which competes with GLW's product) or better yet GE's appliance production division (value unsure - GE unsuccessfully tried to sell this division back in 2008 & wound up using Toyota's Total Production System to revamp their Louisville ops instead.)
Last year Apple announced partnerships with:
BMW, General Motors, Mercedes-Benz, Land Rover, Jaguar, Audi, Toyota, Chrysler & Honda
to introduce iOS & Siri & I can't find a whole lot of info on how this is progressing.
(Maybe I should visit a few car lots...)
Anyways; I paired up (long) with AAPL & GLW since Corning provides glass for iOS & Android products (in addition to being the proven leader in high tech glass display & laboratory products.)
Intel would probably be another pair trade but I just can't seem to make myself do it.
Anyone got any semi solid rumors/factoids about AAPL?
Oh; I switched from a Microsoft brick to a MacBook Pro a little over a year ago & now iHappy.
Sentiment: Strong Buy
Does anyone know of any partnerships Apple has formed in healthcare besides the one with Sanofi which produced the iBGStar blood glucose meter for the iPhone & iPod Touch?
I see on the iBGStar website that they are saying this unit is not for use with the iPhone 5 #$%$?)
Apple has so many possibilities to fuel growth again:
Integrated Healthcare Devices & Big Data Management
Smart Home Appliances
Samsung has a huge advantage in that they are stealing mobile device market share & they already produce home appliances (Apple could try to buy LG Electronics with a market cap of $13.2B & a loss of over $300M last year & not too much debt) Cornhorn would swallow himself...
Next they could try to buy BMW Group (Market cap $61.2B & a ton of debt makes them an LBO target.)
On 2nd thought; maybe BMW wouldn't be such a good idea.
Oh; how about instead, they aggressively pursue development of built in iPad type devices (see Cornings new Willow glass) for all major luxury auto manufacturers.
They could start out elitist with Lexus only (like they did with the iPhone/ATT deal) & then branch out as production/demand warrant.
All of my speculations should most definitely be taken with a huge boulder of salt!
I'm making them here to start some intelligent conversation which may enable us to do a Vulcan mind meld with Cookie & maybe divine some possibilities for this company.
Sentiment: Strong Buy
Samsung is nipping at Apple's heels & may wind up swallowing their legs if they don't wise up!
I recently found this story & believe that Apple could use its huge cash hoard to buy into healthcare & grow into a whole new area of technology.
Merck and Samsung Bioepis Enter Biosimilars Development and Commercialization Agreement.
Under the agreement, Samsung Bioepis will be responsible for preclinical and clinical development, process development and manufacturing, clinical trials and registration. Merck will be responsible for commercialization. Samsung Bioepis will receive an upfront payment from Merck, product supply income and will be eligible for additional payments associated with pre-specified clinical and regulatory milestones. Further financial terms were not disclosed.
“Samsung Bioepis has been building the capabilities needed to develop high-quality biosimilars,” said Christopher Hansung Ko, Ph.D., CEO of Samsung Bioepis. “With this development and commercialization agreement, Samsung takes a significant step toward becoming a major player in the biopharmaceutical industry.”
Samsung Bioepis, a joint venture between Samsung Biologics and Biogen Idec, aims to develop affordable and high-quality biopharmaceutical and biosimilar products.
Samsung already has the lead on connecting us to our home through their appliance manufacturing facilities & they could become the leader in healthy connectivity as well.
Anyone with ideas on what Apple could do in the healthcare arena & home connectivity?
Sentiment: Strong Buy
I believe TEVA will profit on the much touted patent cliff's & they will also add new indications to existing drugs/compounds.
Buy into fear & sell into greed...
I wish TEVA would go down to $30.
I would back my truck in & load up!
P.S. I've already been buying on dips.
Sentiment: Strong Buy
I'm curious to see how well they manage derivative investments this year.
This is a tough environment & the company has to hedge their bets on interest rates.
How talented is Mr. Hele?
Who is his direct report with regards to derivative programs?
I would prefer to see a CEO who decreases his salary in sympathy with decreased earnings & for that reason I believe Mr. Kandarian's words do not jibe with his actions.
He claims the goal of achieving better alignment with the desires of customers, employees & shareholders (cite the "Customer Empathy Program") & yet his compensation increased dramatically in the face of a heavy decline in earnings.
That does not signify "empathy" to me...
I will continue to hold a meager position in MET (purchased at $36 +/-) as I believe the market's sentiment will improve (through selective amnesia) if they see improved dividend payout (awaiting clarity on status as economically important entity) but I will sell when market sentiment changes & transfer the funds into AFL which I perceive to be a significantly better business; run by a team with impeccable character!
The statement you mention shows a disconnect from reality.
How can we expect a guy like that to manage interest rate risk?
However; what bothers me most is the misalignment between the stated goal of value enhancement for customers, employees & shareholders, against actions like increased salaries for poor performance.
Empathy Initiative my hind end; this BOD has no empathy for anyone except themselves.
Most of my investments are in companies I'd like to own forever.
In this case; the position is so small that I'll let it ride as a spec.
I believe the market is still averse to financials & they love a good dividend.
If & when a divvie increase shows; there will be a pile on here & I'll take my meager profit & put it in AFL or one of the others on my watch list (with stable & trustworthy management) which is fairly priced at the time.
I just can't picture Charlie Munger eating lunch with this guy & enjoying it...
Unless of course he enjoyed slicing the dumb SOB with that sharp tongue of his!
Friends of yours?
I work here & am friends with quite a few Brasilians who work for OGXPY & they've heard nothing of this.
Substantiate your statement LumaRumor...
I'm grabbing more today & waiting for FPSO arrivals & subsequent production increases!
$10 by next Spring...
E talvez voce nāo pode fazer amizade; rapaz...
I'm in with a 10 to 15 year horizon on STO.
I believe it present a better value than CVX, COP & all the others...
No short term gains to be had here but as stream of income for a retirement 10 to 15 years from now; IMHO buy!
Once again; your ignorance shines through...
Think Brasilian Portuguese burro!
I own AFL at $40 & change & still consider it a strong buy for my 10 year horizon.
I wish the talking heads would start whining about long term low interest rate environments & their affects on the investment portfolios of financials like AFLAC.
I'd load up the truck sub $40!
10 years from now the psychology/psychosis of the markets will skew in favor of AFLAC.
(Buy into irrational fear & sell into greed - 1 or the other is always available somewhere in the market)
Sentiment: Strong Buy
How can you make a case against the worlds largest generic pharma in the face of the so called patent cliff?
I know; I know, Copaxone (old news & already priced in...)
I do not believe these guys are just sitting on their hands here.
I hope Cramer's little rant sends TEVA sub $30 so I can average down (don't expect much of a move sub $37 though since TEVA is already being ignored by the market.)
Anyone else with a 10 year horizon on TEVA?
It's odd that he practically blew Philip Frost on the show & now he trashes TEVA.
I guess Frost didn't call him after their little love fest & he feels jilted!
Intrinsic value always wins over short term market sentiment!
I added a bit today too & will add more if it dips again.
10 years later = Solid Gain!